Canna Law Blog

MARCH 11, 2024

First introduced in 2023, HB 1453 sought to harmonize the existing medical exemptions from general sales and use taxes with the 37% excise tax on cannabis sales. Primarily, medical cannabis is not recreational or a luxury, but a necessity for many people who suffer from chronic pain, epilepsy, PTSD, and other conditions.

Chronic Pain 107

Chronic Pain Recreational Patients Medicine 107

Veriheal

FEBRUARY 6, 2024

These new proposals are designed to expand access to medical cannabis for NJ MMJ patients. The public comment period is open from October 16 to December 15, 2023. ” Medical and Recreational Cannabis Prices and Availability in New Jersey So why can’t more patients access cannabis in the state?

Programs 67

Programs Access Dispensary Chronic Pain 67

Veriheal

MARCH 6, 2024

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. The HSS found strong scientific support regarding cannabis’ medically beneficial effects for conditions like anorexia , nausea, and chronic pain.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

LifeCannMD

NOVEMBER 21, 2022

Coming in 2023, Floridians will be able to purchase another item at the pump! In Florida, there are many conditions that qualify for medical marijuana including Arthritis, Chronic pain, Insomnia, Multiple Sclerosis?, PTSD, Cancer, Epilepsy, and more.

Chronic Pain 52

Chronic Pain Epilepsy Dispensary Conditions 52

The Cannigma

JULY 12, 2022

A representative from the Alabama Agriculture Department has stated that licenses for medical marijuana producers won’t be issued before September 2022, and it could take until 2023 to get the program up and running. They cannot access flower or edibles and can only have 70 daily doses at one time with a maximum of 50 mg per dose.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Veriheal

MARCH 31, 2023

Fast-forward to 2023, and the state has now granted the first of these psilocybin manufacturing licenses to Satori Farms PDX LLC. Unfortunately, the bill specifies that medical cannabis patients will only have access to a limited selection of cannabis products. Let us know in the comments!

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Veriheal

SEPTEMBER 2, 2022

Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. estimates that 60-70% of his patients are seeking out medical cannabis for the treatment of chronic pain.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57